01 /What it is
CJC-1295 with DAC is a synthetic 30 amino acid GHRH analog. The DAC modification is a maleimide group that binds to serum albumin in research models, giving the molecule an extended active window compared with the no DAC version.
02 /How it works
In growth hormone axis research, CJC-1295 with DAC is studied as a GHRH receptor agonist with a longer plasma window than its no DAC counterpart. Its mechanism is most often investigated alongside ghrelin receptor agonists in synergy studies.
03 /What researchers explore it for
Researchers have explored CJC-1295 with DAC in growth hormone pulsatility research, in extended dose interval research, and in pairing research with selective ghrelin receptor agonists.
04 /Safety and interactions
Research interactions of note include combinations with ghrelin receptor agonists, which are commonly investigated together and can compound observed signaling in research models. CJC-1295 with DAC is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: GHRH analogs. Compared most often with CJC-1295 (no DAC) and Sermorelin. Commonly researched alongside Ipamorelin and GHRP-2.
Related peptides
CJC-1295 (no DAC) · Ipamorelin · GHRP-2